Sameul Fourie

Independent Researcher

Publications

Citations

H-Index

i10-Index

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

A Three-Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines

Mario Campone, Natalya Dobrovolskaya, Serjei Tjulandin, Shin-Chen Chen, Sameul Fourie +5 more

The Breast Journal 2013

P5-19-01: Final Results of a Three-Arm Randomised Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines.

Mario Campone, N. Dobrovolskaya, Sergei Tjulandin, Shuo Chen, Sameul Fourie +5 more

Cancer Research 2011

P180 A cost effectiveness analysis of adjuvant chemotherapy for node positive early breast cancer in South Africa: docetaxel, doxorubicin and cyclophosphamide (TAC) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC)

Bernardo L. Rapoport, S.D. Moodley, Carmel Jacobs, R. Pienaar, Sameul Fourie +1 more

The Breast 2007

Publications

3 total

A Three-Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines

Mario Campone, Natalya Dobrovolskaya, Serjei Tjulandin, Shin-Chen Chen, Sameul Fourie et al. - The Breast Journal, 2013

Cited by 19 OpenAlex

A Three‐Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines OA

M. Campone, N. Dobrovolskaya, S. Tjulandin, Shin‐Chen Chen, S. Fourié - The Breast Journal, 2013

Cited by 21 Semantic Scholar

P5-19-01: Final Results of a Three-Arm Randomised Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines.

Mario Campone, N. Dobrovolskaya, Sergei Tjulandin, Shuo Chen, Sameul Fourie et al. - Cancer Research, 2011

Cited by 2 OpenAlex

5000 A 3-arm randomised phase II study of oral vinorelbine (NVBo) plus capecitabine (X) versus NVBo and X in sequential versus docetaxel (D) plus X in patients with metastatic breast cancer (MBC) previously treated with anthracyclines

M. Campone, N. Dobrovolskaya, S. Tjulandin, S. Chen, S. Fourié - Unknown Venue, 2009

Cited by 2 Semantic Scholar

P180 A cost effectiveness analysis of adjuvant chemotherapy for node positive early breast cancer in South Africa: docetaxel, doxorubicin and cyclophosphamide (TAC) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC)

Bernardo L. Rapoport, S.D. Moodley, Carmel Jacobs, R. Pienaar, Sameul Fourie et al. - The Breast, 2007

Cited by 1 OpenAlex

Research Topics

Breast Cancer Treatment Studies (3) Cancer Treatment and Pharmacology (2) Global Cancer Incidence and Screening (1) HER2/EGFR in Cancer Research (1) Economic and Financial Impacts of Cancer (1)

Frequent Co-Authors

Mario Campone

2 joint publications

F. Mefti

2 joint publications

Florence Lefresne

2 joint publications

Nadege Meheust

2 joint publications

Jacek Jassem

2 joint publications

Natalya Dobrovolskaya

1 joint publication

Affiliations

Chang Gung Memorial Hospital

TW 2011 - 2011

Institut de Cancérologie de l'Ouest

FR 2011 - 2011

Pierre Fabre (France)

FR 2011 - 2011

State Research Center of the Russian Federation

RU 2011 - 2011

Gdańsk Medical University

PL 2011 - 2011

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers

Sameul Fourie

Publication & Citation Trends

Most Cited Works

Publications

A Three-Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines

A Three‐Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines OA

P5-19-01: Final Results of a Three-Arm Randomised Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines.

5000 A 3-arm randomised phase II study of oral vinorelbine (NVBo) plus capecitabine (X) versus NVBo and X in sequential versus docetaxel (D) plus X in patients with metastatic breast cancer (MBC) previously treated with anthracyclines

P180 A cost effectiveness analysis of adjuvant chemotherapy for node positive early breast cancer in South Africa: docetaxel, doxorubicin and cyclophosphamide (TAC) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC)

Research Topics

Frequent Co-Authors

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back